arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

QUEST DIAGNOSTICS INC

DGX
$238.30 ▼ -0.27 (-0.11%) at close
Healthcare ·Services-Medical Laboratories ·USServices-Medical Laboratories
75 Visible periods
34 Metrics
Peer-ranked Benchmarks
Price Chart
68
Health
Good
Bullish
auto_awesome

Analytical Summary

QUEST DIAGNOSTICS INC shows strong fundamentals with top-quartile Return on Common Equity (%). The company's metrics support a bullish outlook for growth-oriented investors.

Market Cap $26.5B
Dividend Yield 0.36%
Revenue Growth 10.2%
Op. Margin 15.1%
ROIC 2.8%
FCF / Share $4.14
Trailing P/E 82.7x
Price / Book 3.5x
FCF Yield 1.7%
Debt / Equity 0.75
info Valuation on last close. End-of-day price, Aug 7, 2026.

75-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$3.04B
↑ +10.2%
Net Income Profit after all expenses
$320.00M
↑ +13.5%
Operating Margin Operating profit as % of sales
15.1%
↑ +9.4% 65th
FCF / Share Free cash flow per share
$4.14
↑ +177.4%
Long-Term Debt Long-term obligations
$5.64B
↓ -0.5%
trending_up

Bullish Indicators

  • Return on Common Equity (%)Return on Common Equity (%) is in the top quartile
warning

Bearish Risks

  • No bearish risks detected.

Health Breakdown

Profitability
65
Returns
78
Financial Health
55
Cash Quality
78

Dividend History

Dividend / share · sourced from SEC filings
$1.80 Latest / share
+9.1% YoY
+10.9% 4-yr CAGR

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 20 years · 75 quarters